{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:40:15Z","timestamp":1756183215124,"version":"3.44.0"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2025.1656972","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:12:53Z","timestamp":1756181573000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing vitiligo care in Russia: landscape, lessons, and a scalable digital health strategy"],"prefix":"10.3389","volume":"12","author":[{"given":"Maria","family":"Borodina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Sigova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Lomonosov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Suvorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/dth.12121","article-title":"Acridone acetic acid, sodium salt, as an agent to stop vitiligo progression: a pilot study","volume":"27","author":"Korobko","year":"2014","journal-title":"Dermatol Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1504460","DOI":"10.3389\/fmed.2025.1504460","article-title":"Vitiligo: a call for paradigm shift toward comprehensive patient care","volume":"12","author":"Sigova","year":"2025","journal-title":"Front Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1016\/S2468-2667(24)00026-4","article-title":"Estimating the burden of vitiligo: a systematic review and modelling study","volume":"9","author":"Akl","year":"2024","journal-title":"Lancet Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/jdv.18050","article-title":"Prevalence of most common skin diseases in Europe: a population-based study","volume":"36","author":"Richard","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/jdv.18257","article-title":"Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA","volume":"36","author":"Bibeau","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B6","unstructured":"RKKVD of the Ministry of Health of the Republic of Tatarstan named after Prof. A.G. Ge"},{"key":"B7","unstructured":"Research Program in Vitiligo Patients [Media Release]\n          \n          2025"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e12620","DOI":"10.1111\/dth.12620","article-title":"Patient-reported outcomes: a 5-year long study reveals previously unreported therapeutic, demographic, socio-economic, and other correlations in vitiligo","volume":"31","author":"Valle","year":"2018","journal-title":"Dermatol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.17816\/dv487099","article-title":"Psychosomatic aspects of vitiligo","volume":"26","author":"Mohammed Al-Janabi","year":"2023","journal-title":"Russ J Skin Vener Dis"},{"key":"B10","unstructured":"Moscow: Russian Society of Dermatovenerologists and Cosmetologists (2015)\n          \n          16"},{"key":"B11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.17816\/dv625814","article-title":"Decades of experience treating vitiligo with UVB therapy","volume":"27","author":"Olisova","year":"2024","journal-title":"Russ J Skin Vener Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"114527","DOI":"10.1016\/j.ejmech.2022.114527","article-title":"A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships","volume":"239","author":"Yadav","year":"2022","journal-title":"Eur J Med Chem"},{"key":"B13","unstructured":"Synthesis and study of antibacterial activity of some fluorosubstituted acridone derivatives\n          \n          3\n          5\n          \n            \n              Kudryavtseva\n              TN\n            \n            \n              Bogatyrev\n              KV\n            \n            \n              Sysoev\n              PI\n            \n            \n              Zar\n              HY\n            \n            \n              Klimova\n              LG\n            \n          \n          Fluorine Notes\n          87\n          2013"},{"key":"B14","unstructured":"Scientists of Sechenov University and Residents of Skolkovo Have Created a Program to Identify Skin Problems\n          \n          2023"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1656972\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:12:56Z","timestamp":1756181576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1656972\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":14,"alternative-id":["10.3389\/fmed.2025.1656972"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1656972","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"article-number":"1656972"}}